Thought Leadership Highlight – Cofounders of DrChrono
Posted On November 12, 2013
Michael Nusimow, CEO, and Daniel Kivatinos, COO, co-founders of drchrono discuss the company, its goals, how to disrupt health IT and how mobile is being embraced by those in healthcare.
Tell me about drchrono, mission, goals and how it fits into the current landscape.
drchrono created a free electronic medical record (EMR) platform on the iPad, iPhone and cloud, and recently announced its newest app for iOS7. This is the first mobile EHR to support Apple’s new iOS7. Physicians are using mobile devices such as the iPad as a key business tool in their practice and it’s drchrono’s mission to enable the world’s doctors and patients to be better connected.
On a more local level, we are looking to bring Silicon Valley technology and people into the forefront of the healthcare space. We are using cutting edge technologies like the iPad and SaaS software to deliver clinical and business tools for office based doctors.
Why use your talents in health IT? What drives you to serve this space?
We went to college together back East and several years after graduating we met up to learn that we both had family members with unfavorable healthcare experiences. We felt this urge to improve healthcare practices starting at the physician/patient level. We realized that a healthcare system built on faxing and shuffling papers is inefficient and thought so much more could be done to streamline the process via new technologies.
Based on our experiences, we witnessed that many office-based doctors were using paper charts for clinical work. If they have a patient taking 10 or more drugs or who has a very complex chart, they will waste a lot of time trying to understand the entire patient’s history. Seeing this need and personally suffering through bad healthcare experiences due to inefficiencies was the inspiration to start drchrono with the goal to digitize healthcare. We both knew we could build a software application that would create a better care experience.